Asthma, Bronchial

24 registered clinical trials studyying Asthma, Bronchial — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Non-interventional, Prospective Study With Benralizumab NCT06422078	AstraZeneca	—
Terminated	REACT - REAl Care for AsThma - A Disease Study to Identify Patients With Severe Uncontrolled Asthma NCT06299306	AstraZeneca	—
Recruiting	The Cohort Study for Asthma in China NCT05937334	Beijing Chao Yang Hospital	—
Completed	Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and NCT05270278	Value Outcomes Ltd.	—
Withdrawn	Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma. NCT03989635	Novartis Pharmaceuticals	Phase 2
Completed	Sleep Apnea in Asthmatic Children and Teenagers NCT03034447	Federal University of São Paulo	N/A
Completed	Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACV NCT02805907	MurciaSalud	Phase 4
Completed	Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic NCT02227394	Zambon SpA	Phase 2
Unknown	Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Techn NCT00644462	KarmelSonix Ltd.	—
Withdrawn	A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects NCT00830427	Pfizer	Phase 2
Completed	The Effects of Exercise on Physiological and Psychological Parameters in an Asthmatic Population NCT00825903	Washington State University	N/A
Completed	Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma NCT00734318	Mundipharma Research Limited	Phase 3
Completed	Wheeze Detection in Children During Dynamic Bronchial Situations Measured by WIM-PC™ Recording NCT00640120	KarmelSonix Ltd.	—
Withdrawn	A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0 NCT00540839	Organon and Co	Phase 3
Completed	The Mannitol-Asthma-Ciclesonide-Study NCT03839433	Cantonal Hosptal, Baselland	Phase 4
Terminated	Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adult NCT00385593	AstraZeneca	Phase 3
Unknown	Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide NCT00312312	Bispebjerg Hospital	N/A
Completed	Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma NCT00213252	The Hospital for Sick Children	Phase 2
Completed	An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269) NCT00092885	Organon and Co	Phase 3
Completed	Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254) NCT00092092	Organon and Co	Phase 4
Completed	Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) NCT00092105	Organon and Co	Phase 3
Completed	A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910 NCT00489346	Organon and Co	Phase 3
Completed	Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma NCT00189787	Astellas Pharma Inc	Phase 2
Completed	Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persiste NCT00189722	Astellas Pharma Inc	Phase 2